Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience
Abstract Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2 infection, which evolved into a global pandemic within a short time. Individuals with sickle cell disease (SCD) suffer from underlying cardiopulmonary comorbidities and are at risk of severe complications such as pneumonia, acute c...
Main Authors: | Preethi Ramachandran, Abhilash Perisetti, Balachandar Kathirvelu, Mahesh Gajendran, Snigdha Ghanta, Ifeanyichkwu Onukogu, Ted Lao, Faiz Anwer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.87 |
Similar Items
-
Empowering patients with sickle cell anemia and their families through innovative educational methods
by: Riley Plett, et al.
Published: (2023-11-01) -
Recent progress in the treatment of sickle cell disease: an up-to-date review
by: Biswajeet Acharya, et al.
Published: (2023-04-01) -
Hematological Indices of Sickle Cell Anaemia Patients with Pulmonary Tuberculosis in Northern Nigeria.
by: Sagir G. Ahmed, et al.
Published: (2010-06-01) -
Hematological Characteristics of a Sample of Iraqi Patients with Sickle Cell Anemia and Their Correlation with Age and Gender
by: Hassan Dede Meshay, et al.
Published: (2022-04-01) -
Hematological Characteristics of a Sample of Iraqi Patients with Sickle Cell Anemia and Their Correlation with Age and Gender
by: Hassan Dede Meshay, et al.
Published: (2022-04-01)